U.S. Food Stock News

In March 2026, a federal antitrust class action was filed against Vail Resorts and Alterra Mountain Company, alleging that their Epic and Ikon ski pass bundles and high single-day lift-ticket prices unlawfully suppress competition and inflate costs for skiers and snowboarders across North America. The lawsuit argues that the two companies’ control over access to nearly all marquee destination ski resorts has left consumers with limited alternatives and pressured independent regional...

RLI (RLI) has reshaped its Claims leadership by promoting Cory Figiel to Chief Claim Officer and Charles Spiekerman to Vice President of Claim, following the retirement of long-serving executive Bob Handzel. See our latest analysis for RLI. Leadership changes in the Claim organization come as the share price trades at US$58.14, with a 1 day share price return of 2.11% and a 1 year total shareholder return decline of 21%, suggesting recent momentum has softened after a stronger five year total...

Sun Cruiser White Tea + Vodka launch puts Boston Beer Company (SAM) in focus Boston Beer Company (SAM) is back on investor radars after its Sun Cruiser brand introduced White Tea + Vodka, a non carbonated ready to drink line that is positioned around lighter calories and sugar. See our latest analysis for Boston Beer Company. The new Sun Cruiser line lands at a time when momentum in Boston Beer Company’s share price has picked up, with a 21.71% 90 day share price return and a 20.51% year to...

Resideo Technologies earnings spark fresh look at the stock Resideo Technologies (REZI) has moved back into focus after its latest earnings announcement, where the company issued robust 2025 guidance and reported that it exceeded its Q4 2025 financial outlook, drawing fresh attention from investors. See our latest analysis for Resideo Technologies. The earnings update appears to have helped shift sentiment, with a 7 day share price return of 3.99% and a 1 year total shareholder return of...

Ocular Therapeutix recently announced that it will present additional data and analyses from its Phase 3 SOL-1 superiority trial of AXPAXLI for wet age-related macular degeneration at multiple scientific conferences in April 2026, highlighting durability, efficacy, and safety outcomes. These upcoming scientific presentations are set to put AXPAXLI’s clinical profile under closer scrutiny from physicians and researchers, potentially sharpening how the therapy is perceived within the...

Why Jabil (JBL) Is On Investors’ Radar Today Jabil (JBL) has drawn fresh attention after recent trading, with the stock last closing at $268.55. Investors are weighing this price against its recent performance and the company’s current fundamentals. See our latest analysis for Jabil. Although the share price slipped 1.25% over the last trading day, Jabil’s 11.39% 1 month share price return and very strong 1 year total shareholder return of 130.12% suggest that momentum has been building over...

GeneDx Holdings (WGS) recently drew attention after a 21% share price drop, as bearish technical signals, mixed analyst views, and institutional fund outflows contrasted with a more upbeat stance from some retail investors. See our latest analysis for GeneDx Holdings. Short term momentum has been volatile, with a 1 day share price return of 1.04% and a 7 day gain of 15.96%, following a 30 day share price decline of 24.87% and a year to date share price return of 49.96% in the red. The 3 year...

Amalgamated Financial recently reported fourth-quarter 2025 results with revenue coming in ahead of forecasts, alongside a two-year improvement in net interest margin and compounded earnings per share growth, while an executive filed planned insider stock sales under a Rule 10b5-1 plan. The combination of stronger-than-expected revenue, enhanced profitability from core lending, and easing but still positive revenue growth has sharpened attention on how efficiently Amalgamated is converting...

Tsakos Energy Navigation recently presented at the Lytham Partners 2026 Industrials & Basic Materials Summit after reporting fourth-quarter 2025 earnings per share of US$1.70 and revenue that both surpassed analyst forecasts by wide margins. The combination of a meaningful earnings surprise and revenue outperformance has prompted closer attention to how Tsakos Energy Navigation’s operating performance aligns with its longer-term business outlook. We’ll now examine how this strong...

Why Axos Financial Is On Investors’ Radar Axos Financial (AX) has drawn attention recently as investors weigh its current share price of US$85.36 against long term return figures and profitability metrics, looking for signals on whether the recent pullback offers value. See our latest analysis for Axos Financial. Recent trading has been mixed, with a 2.9% 7 day share price return set against a 4.6% 90 day share price decline. At the same time, the 1 year total shareholder return of 47.6%...

FLEX LNG (NYSE:FLNG) has secured a new time charter for its Flex Aurora vessel with a global Supermajor. The agreement is a two-year firm deal with options that could extend employment through 2034. See our latest analysis for FLEX LNG. The new charter lands at a time when FLEX LNG’s share price has a 90-day share price return of 23.31% and a 1-year total shareholder return of 67.73%. This suggests momentum has been building around the stock’s income and contract visibility story. If this...

Recent performance snapshot for Atmus Filtration Technologies (ATMU) With no single headline event driving attention, Atmus Filtration Technologies (ATMU) has attracted interest based on its recent trading record, value metrics and core filtration business across commercial and industrial vehicle markets. See our latest analysis for Atmus Filtration Technologies. At a share price of US$57.62, Atmus Filtration Technologies has seen short term share price softness with a 1 day return of 0.86%...

Recent analyst moves around Bank of America (BAC) have drawn fresh attention to the stock, as upgrades, new coverage and a focus on earnings consistency and capital returns shape how investors are reassessing the bank. See our latest analysis for Bank of America. At a share price of $49.38, Bank of America has a 7 day share price return of 5.13% but a 90 day share price return decline of 13.2%, while the 1 year total shareholder return of 46.82% and 3 year total shareholder return of 91.73%...

What J.B. Hunt’s Recent Performance Tells You J.B. Hunt Transport Services (JBHT) has drawn investor attention after a solid run, with the stock showing a 0.7% return over the past month and 6.4% over the past 3 months. These moves sit alongside a 61.4% total return over the past year and 9.2% year to date. This performance has prompted a closer look at how its current valuation compares with the underlying business. See our latest analysis for J.B. Hunt Transport Services. With the share...

Why Sealed Air Is On Investors’ Radar Sealed Air (SEE) has been drawing attention after recent share price moves, prompting investors to take a fresh look at its packaging business, current valuation signals, and how its returns have varied across different time frames. See our latest analysis for Sealed Air. The share price at US$42.08 has been relatively steady in the short term, while the 1 year total shareholder return of 76.16% contrasts with flat to slightly negative total shareholder...

In recent weeks, Matador Resources has been influenced by Middle East tensions that pushed crude prices higher, followed by de-escalation that eased oil markets and prompted profit-taking across energy names. At the same time, Matador’s consistent outperformance versus earnings expectations and supportive analyst views have become increasingly important in shaping how investors interpret short‑term oil price swings for the company. We’ll now examine how this mix of geopolitically driven oil...

Helmerich & Payne (HP) has closed the sale of its Utica Square retail property to funds managed by Northwood Investors, using the after tax proceeds to retire most of its remaining term loan balance. See our latest analysis for Helmerich & Payne. At a share price of $34.81, Helmerich & Payne has delivered a 16.27% year to date share price return and an 83.50% total shareholder return over the past year, suggesting positive momentum despite a recent 3.71% 7 day share price pullback. Balance...

In late March 2026, Plains GP Holdings, L.P. filed shelf registrations for its Class A common shares, covering up to US$938.9 million in potential future issuances. This move gives the company additional flexibility to tap equity markets over time, a step that can meaningfully influence how investors think about future capital raising and ownership dilution. Next, we'll examine how this new US$938.9 million Class A share shelf registration could influence Plains GP Holdings' investment...

Why the HISA court ruling matters for Churchill Downs (CHDN) The recent federal court ruling that the Horseracing Integrity and Safety Authority acted unlawfully on purse weighted fees puts Churchill Downs (CHDN) at the center of a key regulatory shift in US horse racing. See our latest analysis for Churchill Downs. At a share price of $89.07, Churchill Downs has seen a 5.38% 7 day share price return and 6.25% 30 day share price return, but longer term total shareholder returns over 1, 3 and...

Recently, all six AI models covering Marten Transport downgraded the company, citing weak freight fundamentals, declining profitability, and negative free cash flow despite a strong balance sheet and improving technical trend. This wave of AI-driven downgrades highlights how Marten’s outlook is now heavily tethered to a broader freight market recovery rather than company-specific initiatives. We’ll now examine how these AI-model downgrades and the pressure from weak freight fundamentals...

In late March 2026, Regencell Bioscience Holdings filed a shelf registration and announced an at-the-market follow-on equity offering of up to US$500 million in common stock. This move signals that the company is building flexibility to raise substantial capital over time, potentially reshaping its funding mix and balance sheet. We will now examine how this sizeable at-the-market equity program may influence Regencell Bioscience Holdings’ investment narrative and risk profile. The latest...

Why Casey's latest outlook update matters for CASY shares Casey's General Stores (CASY) recently drew investor attention after reporting year-over-year profit growth. The company lifted diluted EPS by 50% and EBITDA by 27.5%, while also raising its fiscal 2026 guidance. See our latest analysis for Casey's General Stores. Investors appear to have welcomed the stronger outlook, with a 30 day share price return of 11.86% and a 1 year total shareholder return of 79.54%. This suggests momentum has...

EverCommerce (EVCM) shares came under pressure after the company released its Q4 earnings and issued guidance for Q1 and full year 2026, as broader geopolitical volatility added to the market reaction. See our latest analysis for EverCommerce. At a share price of $11.71, EverCommerce has seen a 1.65% 1 day share price return and a 3.08% 7 day share price return. Its 1 year total shareholder return of 22.23% points to solid long term momentum despite recent shorter term share price...

In March 2026, Genius Sports announced a major expansion of its Moment Engine, integrating real-time, AI-driven sports advertising technology across partners that now cover about 90% of the programmatic advertising ecosystem, supported by new collaborations with DIRECTV Advertising, major ad-tech platforms, and Publicis Sports. This push to make Moment Engine an execution layer for live sports advertising suggests Genius Sports is deepening its role at the intersection of official data, AI,...